Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
8.77
-0.45 (-4.88%)
At close: Sep 25, 2026, 4:00 PM EDT
8.82
+0.05 (0.57%)
After-hours: Sep 25, 2026, 7:58 PM EDT
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $261.08 million as of September 25, 2026. Its market cap has increased by 1,044.60% in one year.
Market Cap
261.08M
Enterprise Value
160.10M
1-Year Change
1,044.60%
Ranking
Category
Stock Price
$8.77
ChartMarket Cap Chart
Since March 26, 2024, Q32 Bio's market cap has increased from $199.19M to $261.08M, an increase of 31.07%. That is a compound annual growth rate of 11.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 261.08M | 539.11% |
| Dec 31, 2025 | 40.85M | -2.51% |
| Dec 31, 2024 | 41.90M | -78.96% |
| Mar 26, 2024 | 199.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 276.26M |
| Invivyd | 275.36M |
| Vicore Pharma Holding AB | 272.51M |
| Lexeo Therapeutics | 271.56M |
| Greenwich LifeSciences | 267.44M |
| Sutro Biopharma | 264.97M |
| Lineage Cell Therapeutics | 260.49M |
| Bicycle Therapeutics | 257.92M |